New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 24, 2014
04:55 EDTCRME, CRME, ALR, ALR, GALE, GALE, BIND, BIND, AVNR, AVNR, OCRX, OCRX, ONVO, ONVO, OSIR, OSIR, SGNT, SGNT, SNTA, SNTA, CRIS, CRISJMP Securities to hold a conference
Healthcare Conference to be held in New York on June 24-25.
News For CRME;SNTA;SGNT;OSIR;ONVO;OCRX;AVNR;BIND;GALE;ALR;CRIS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 30, 2014
16:07 EDTAVNRAvanir publishes AVP-825 Phase III results
Subscribe for More Information
October 29, 2014
10:00 EDTAVNROn The Fly: Analyst Initiation Summary
Subscribe for More Information
10:00 EDTALROn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AMC Networks (AMCX) upgraded to Buy from Hold at ISI Group... Abbott (ABT) upgraded to Buy from Hold at Deutsche Bank... Ahold (AHONY) upgraded to Overweight from Neutral at JPMorgan... Alere (ALR) upgraded to Buy from Hold at Craig-Hallum... Ambev (ABEV) upgraded to Buy from Neutral at Goldman... Bayer (BAYRY) upgraded to Outperform from Market Perform at Bernstein... C.H. Robinson (CHRW) upgraded to Buy from Neutral at BofA/Merrill... Cliffs Natural (CLF) upgraded to Outperform from Neutral at Macquarie... HCC Insurance (HCC) upgraded at Raymond James... Hannon Armstrong (HASI) upgraded to Buy from Neutral at BofA/Merrill... Jamba (JMBA) upgraded to Outperform from Neutral at Wedbush... Midway Gold (MDW) upgraded to Speculative Buy from Hold at Canaccord... PG&E (PCG) upgraded to Buy from Hold at Deutsche Bank... RWE AG (RWEOY) upgraded to Neutral from Underweight at JPMorgan... Starwood (HOT) upgraded to Buy from Hold at Craig-Hallum... Total System (TSS) upgraded to Overweight from Equal Weight at Stephens.
07:58 EDTALRAlere upgraded to Buy from Hold at Craig-Hallum
07:23 EDTAVNRAvanir initiated with a Buy at BofA/Merrill
Subscribe for More Information
07:09 EDTSNTASynta Pharmaceuticals announces initiation of I-SPY 2 trial of Ganetespib
Subscribe for More Information
October 28, 2014
10:40 EDTALRHigh option volume stocks
Subscribe for More Information
07:36 EDTALRAlere reports Q3 Professional Diagnostics net product/services revenue $581.8M
U.S. influenza and meter-based Triage product revenues were $15M and $15.8M, respectively, for Q3. Net product and services revenue from our Health Information Solutions segment was $123.9M in Q3.
07:35 EDTALRAlere reports Q3 non-GAAP EPS 48c, consensus 52c
Subscribe for More Information
07:33 EDTALRAlere names Namal Nawane CEO and President
Alere announced that Namal Nawana has been named CEO, President, and a member of the board. Nawana joined Alere in December 2012 as COO and was appointed Interim CEO and President of Alere in July.
07:21 EDTCRISCuris announces allowance of U.S. patent
Curis announced the receipt of a Notice of Allowance of a U.S. patent that covers a broad genus of compounds that target histone deacetylase, or HDAC, and phosphoinositide 3-kinase, or PI3K, activities in a single chemical structure including CUDC-907, Curis' oral, dual HDAC and PI3K small molecule inhibitor that is currently being studied in Phase 1 clinical trials. This patent, along with prior patents issued to Curis, further strengthens the Company's intellectual property portfolio of compounds including CUDC-907 that inhibit HDAC and PI3K enzymes in a single small molecule for the treatment of certain human diseases. Collectively, these patents generically cover composition-of-matter and methods of use of CUDC-907 as well as a broad range of proprietary chemical entities that target HDAC and PI3K enzymes, and in some instances mammalian target of rapamycin, within a single molecule for the treatment of certain human diseases.
October 22, 2014
14:08 EDTGALEGalena files to sell 2M shares of common stock for holders
Subscribe for More Information
October 21, 2014
07:07 EDTONVOMecklerMedia to hold a conference
Inside 3D Printing Conference is being held in Santa Clara, California on October 21-23.
October 17, 2014
08:05 EDTOSIROsiris, Arthrex announce exclusive commercial and development partnership
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use